Krka Reports Annual Profits of EUR 40 Million
Novo Mesto, 28 February - Slovenia's leading pharmaceutical company Krka performed very well in 2001, posting annual net profits of SIT 9.1 billion (EUR 40.73 million), a jump of 27.5 percent compared to the previous year, the company said on Thursday.
The rest of this news item is available to subscribers.
The news item consists of 1.162 characters (without spaces) or 225 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.